NCT05498896 Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05494619 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) Status WITHDRAWN Phase PHASE3
NCT05487248 A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT05478135 A Remote Evaluation of NAVIFY Oncology Hub Using Clinical Simulation Status COMPLETED Phase NA
NCT05476926 A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05459129 A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer) Status COMPLETED Phase PHASE1/PHASE2
NCT05457998 BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers Status ENROLLING_BY_INVITATION Phase N/A
NCT05419388 A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT05415215 A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT05401565 Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD) Status COMPLETED Phase PHASE2
NCT05399550 Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema Status WITHDRAWN Phase PHASE2
NCT05377034 Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients Status RECRUITING Phase PHASE2
NCT05364424 A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT05326009 A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease Status UNKNOWN Phase N/A
NCT05315713 An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT05307679 A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome Status TERMINATED Phase PHASE2
NCT05296798 A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) Status ACTIVE_NOT_RECRUITING Phase PHASE3